Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
$260M |
| 2 |
Y
Alleghany Corporation
Y
|
$139M |
| 3 |
FBC
Flagstar Bancorp, Inc. New
FBC
|
$137M |
| 4 |
NLSN
Nielsen Holdings plc
NLSN
|
$121M |
| 5 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
$86.4M |
Sector Composition
| 1 | Financials | 15.11% |
| 2 | Technology | 12.49% |
| 3 | Industrials | 10.83% |
| 4 | Healthcare | 9.96% |
| 5 | Consumer Discretionary | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Procter & Gamble
PG
$368B
| $1.28M | 0.38% | 8,465,873 -473,173 | -5% | -$71.7K |
|
27
Shell
SHEL
$215B
| $1.26M | 0.37% | 22,060,347 +1,992,903 | +10% | +$113K |
|
28
Mastercard
MA
$538B
| $1.23M | 0.36% | 3,543,796 +19,915 | +0.6% | +$6.93K |
|
29
Meta Platforms (Facebook)
META
$1.86T
| $1.2M | 0.36% | 10,010,437 -755,167 | -7% | -$90.9K |
|
30
AbbVie
ABBV
$372B
| $1.2M | 0.36% | 7,453,275 +7,145 | +0.1% | +$1.16K |
|
31
UnitedHealth
UNH
$281B
| $1.2M | 0.35% | 2,259,673 -211,894 | -9% | -$112K |
|
32
Bank of America
BAC
$376B
| $1.2M | 0.35% | 36,114,887 +576,954 | +2% | +$19.1K |
|
33
Thermo Fisher Scientific
TMO
$186B
| $1.19M | 0.35% | 2,168,072 -55,798 | -3% | -$30.7K |
|
34
Eli Lilly
LLY
$657B
| $1.17M | 0.34% | 3,186,464 +54,887 | +2% | +$20.1K |
|
35
Visa
V
$683B
| $1.15M | 0.34% | 5,521,362 -84,626 | -2% | -$17.6K |
|
36
Home Depot
HD
$405B
| $1.14M | 0.34% | 3,604,365 +90,096 | +3% | +$28.5K |
|
37
PepsiCo
PEP
$204B
| $1.09M | 0.32% | 6,050,275 -106,791 | -2% | -$19.3K |
|
38
Elevance Health
ELV
$71.8B
| $1.07M | 0.32% | 2,091,804 -127,658 | -6% | -$65.5K |
|
39
Merck
MRK
$210B
| $1.03M | 0.3% | 9,262,310 +476,216 | +5% | +$52.8K |
|
40
Broadcom
AVGO
$1.4T
| $1.02M | 0.3% | 1,820,997 -32,786 | -2% | -$18.3K |
|
41
AT&T
T
$209B
| $957K | 0.28% | 51,975,239 -1,406,961 | -3% | -$25.9K |
|
42
Bristol-Myers Squibb
BMY
$96B
| $908K | 0.27% | 12,614,838 -2,045,144 | -14% | -$147K |
|
43
CVS Health
CVS
$92.8B
| $901K | 0.27% | 9,671,172 +132,105 | +1% | +$12.3K |
|
44
Coca-Cola
KO
$297B
| $894K | 0.26% | 14,049,563 -205,886 | -1% | -$13.1K |
|
45
Cigna
CI
$80.3B
| $890K | 0.26% | 2,687,302 +517 | +0% | +$171 |
|
46
Morgan Stanley
MS
$240B
| $821K | 0.24% | 9,656,692 +111,008 | +1% | +$9.44K |
|
47
Goldman Sachs
GS
$226B
| $814K | 0.24% | 2,371,439 -105,326 | -4% | -$36.2K |
|
48
Wells Fargo
WFC
$263B
| $809K | 0.24% | 19,602,513 +571,850 | +3% | +$23.6K |
|
49
Equinix
EQIX
$76.9B
| $805K | 0.24% | 1,229,005 +3,101 | +0.3% | +$2.03K |
|
50
Danaher
DHR
$147B
| $804K | 0.24% | 3,027,388 +90,780 | +3% | +$24.1K |
|